05/10/2024
3:37 PM | Cumberland Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2024
4:14 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2024
7:22 PM | Cumberland Pharmaceuticals (Issuer)
Hamm John M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
7:24 PM | Anthony Todd M. (Reporting)
Cumberland Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
7:25 PM | Bitterman Chris T. (Reporting)
Cumberland Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
7:26 PM | Cumberland Pharmaceuticals (Issuer)
Herman James L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
7:28 PM | Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/26/2024
7:29 PM | Brown Martin S JR (Reporting)
Cumberland Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
7:31 PM | Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
7:31 PM | Cumberland Pharmaceuticals (Issuer)
Galante Joseph C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
7:32 PM | Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
7:33 PM | Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
4:15 PM | Cumberland Pharmaceuticals (Filer)
| Form 424B5 | |
03/20/2024
4:20 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
4:03 PM | Cumberland Pharmaceuticals (Filer)
| Form DEF 14A | |
03/13/2024
4:04 PM | Cumberland Pharmaceuticals (Filer)
| Form DEFA14A | |
03/05/2024
4:10 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/09/2024
4:27 PM | Cumberland Pharmaceuticals (Subject)
| Form SC 13G | |
12/28/2023
4:07 PM | Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
4:08 PM | Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
4:10 PM | Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
4:11 PM | Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2023
11:15 PM | Cumberland Pharmaceuticals (Filer)
| Form EFFECT | |
12/14/2023
4:09 PM | Cumberland Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
12/06/2023
4:01 PM | Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
| Form 4/A | |
12/06/2023
4:02 PM | Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2023
4:03 PM | Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2023
4:04 PM | Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2023
4:05 PM | Cumberland Pharmaceuticals (Issuer)
Hamm John M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
7:15 AM | Cumberland Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023
4:21 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2023
4:04 PM | Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/13/2023
8:11 AM | Cumberland Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2023
8:24 AM | Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/08/2023
4:04 PM | Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/08/2023
4:04 PM | Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/11/2023
4:05 PM | Cumberland Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2023
4:23 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2023
4:20 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2023
4:01 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/02/2023
4:18 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
This military-backed stock “owns” AI market (Ad) The AI boom is just getting started.
And the real wealth has still to be made… You must read this new presentation from Porter Stansberry. |
